Age3 yrs
Real estate1 parcel · 2,177 m²
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of EYE CLINIC is 0.3% (very low). The 2024 annual accounts show equity of €16k and a net result of €-37k. Its solvency ranks better than 6% of 6596 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.3%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+Annual accounts: weaker financial profile
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Signals
1 signal · with evidenceWeak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 6% of 6596 sector peers (2024).
View the sector comparison Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Filing behaviour
From the deposit records, complete market-wideDeadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 29 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-07-2025, 1 day ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 2 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | nothing on record | not filed | - |
| 31-12-2024 | 31-07-2025 | 30-07-2025 | 1 d early | 2025-00345950 |
| 31-12-2023 | 31-07-2024 | 26-08-2024 | 26 d late | 2024-00436044 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsMore than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-37k
Working capital€-104k-143.9%
Annual accounts & ratios
Source: NBB · 2024Annual accounts filed on 30-07-2025 with the NBB · fiscal year 2024 · micro
Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 2.1% | 66.7% | |
| Net result | €-37k | €46k | |
| Equity | €16k | €79k | |
| Gross operating margin | €230k | €78k | |
| Staff costs | €89k | €21k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
€140k
-20.2%
23-24
€-37k
-
23-24
€113k
-21.5%
23-24
€744k
-17.4%
23-24
€16k
-70.2%
23-24
€-104k
-143.9%
23-24
3
+138.5%
23-24
€89k
-16.0%
23-24
Show 11 other metrics
€4k
-
23-24
€729k
-14.2%
23-24
€130k
+0.7%
23-24
€581k
-17.3%
23-24
0.20
-70.1%
23-24
0.20
-70.1%
23-24
2.1%
-63.8%
23-24
46.89
+187.4%
23-24
-235.0%
-
23-24
-4.9%
-
23-24
5.26
-18.3%
23-24
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €140k |
| Net profit | €-37k |
| Cash flow | €113k |
| Staff costs | €89k |
| Income taxes | - |
| Dividends | - |
| Total assets | €744k |
| Equity | €16k |
| Debt | €729k |
| of which ≤ 1y | €130k |
| of which > 1y | €581k |
| Working capital | €-104k |
| Employees (FTE) | 3.1 |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 0.20 |
| Quick ratio | 0.20 |
| Working capital ratio | -14.0% |
| Solvency | 2.1% |
| Debt / equity | 46.89 |
| Long-term debt ratio | 37.36 |
| Interest coverage | 5.26 |
| Gross margin | - |
| Net margin | - |
| ROA | -4.9% |
| ROE | -235.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2024
Full annual accounts (22 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €744k |
| Fixed assets | 21/28 | €718k |
| Intangible fixed assets | 21 | €473k |
| Tangible fixed assets | 22/27 | €245k |
| Financial fixed assets | 28 | €433 |
| Current assets | 29/58 | €26k |
| Amounts receivable within one year | 40/41 | €9k |
| Cash & bank | 54/58 | €14k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €744k |
| Equity | 10/15 | €16k |
| Contributions / capital | 10/11 | €45k |
| Accumulated profits (losses) | 14 | €-29k |
| Amounts payable | 17/49 | €729k |
| Amounts payable after one year | 17 | €581k |
| Amounts payable within one year | 42/48 | €130k |
| Income statement | ||
| Gross operating margin | 9900 | €230k |
| Operating result | 9901 | €-10k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €27k |
| Result before taxes | 9903 | €-37k |
| Net result for the period | 9904 | €-37k |
| Result to be appropriated | 9905 | €-37k |
This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2024 · computed20
/ 100
Critical
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Structure & network
Locations & real estate
Registered office
on the map · from the address registerEstablishment units
1 locationEYE CLINIC
since 20222.337.841.936
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area2,177 m²
Buildings1
Building footprint212 m²
Volume (LiDAR)2,946 m³
Tallest building16.8 m · ±5 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25112M0978/00V002 | Wallonia | 2,177 m² | 1 · 212 m² | 16.8 m · 5 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
1 act Address history · 1
20-06-2023
Registered-office move
All acts · 1
updated 3 years ago
2023
20-06-2023 Registered office moved within Wavre
- Chaussée de Louvain 43 Boîte 4 - 1300 Wavre → Chaussée de Louvain n° 43 bte 2, et ce à dater de ce jour
Analysis
Financial profile
5 of 5 axes measured29
/ 100
Fragile profile, watch profitability in particular.
All 5 axes are computed from data Checked has read.
Health
20
Profitability
0
Solvency
1
Growth
32
Stability
94
Credit advice
verdict per customer and amountSimilar
Similar companies
Comparable size, same sectorBE 0770.630.554 · Bilzen-Hoeselt
BE 1027.561.184 · Beauvechain
BE 0764.594.679 · Antwerpen
BE 0789.659.875 · Maaseik
BE 0803.151.783 · Antwerpen
We hold annual accounts for 1,993 of the 16,623 companies in this sector. 979 of them are within a factor 10 of this company's equity.
Company registry
Company registry (CBE)
Crossroads BankActivities
Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
| Legal nameFR | EYE CLINIC |
Registered office
Chaussée de Louvain 43 bus 2
1300 Wavre, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.